Page 77 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Clinical Use of HBsAg quantification Lehar 3
Lehar 4
7:30 - 8:30 Moderators:
George Papatheodoridis, Greece Stolz 1
Jörg Petersen, Germany Stolz 2
Schubert 1
Regression of fibrosis/cirrhosis: clinical implications Schubert 2 SCIENTIFIC PROGRAMME

7:30 - 8:30 Moderators: 77
Vincent Mallet, France
Francesco Paolo Russo, Italy

IFN-free regimens in the OLT setting

7:30 - 8:30 Moderators:
Stefano Fagiuoli, Italy
Xavier Forns, Spain

Novel treatments in autoimmune liver disease

7:30 - 8:30 Moderators:
Gideon Hirschfield, The United Kingdom
Christoph Schramm, Germany

Selection of patients for TACE

7:30 - 8:30 Moderators:
Joong-Won Park, South Korea
Wolfgang Sieghart, Austria

Optimal Management of IFN containing regimens

7:30 - 8:30 Moderators:
José Luis Calleja, Spain
Maria Grazia Rumi, Italy

Vienna, Austria • April 22–26, 2015